TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Pilot's drug test may be a false reading: AirAsia
AirAsia Indonesia CEO Sunu Widyatmoko confirmed Thursday that one of his airlineâs pilots had tested positive for drug use, however, he stated that the test result could be related to the pilotâs recent discharge from hospital
Change text size
Gift Premium Articles
to Anyone
Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
A
irAsia Indonesia CEO Sunu Widyatmoko confirmed Thursday that one of his airline's pilots had tested positive for drug use, however, he stated that the test result could be related to the pilot's recent discharge from hospital.
The pilot, with initials FI, tested positive for morphine after being subjected on Thursday to a random urine test conducted by the Transportation Ministry in Bali following the AirAsia flight QZ8501 accident.
'After interviewing the pilot, we found that he had recently been discharged from hospital after being treated for typhus. On the day of his drug test, he was still taking prescribed medication, one of which was [a cough medicine] Actifed,' Sunu said on Thursday, as quoted by kompas.com.
Sunu said that the prescription medication may have triggered a false reading and that AirAsia would conduct further tests on the pilot.
According to the airline, FI was regarded as having an excellent track record and had worked for nine years with the airline.
FI has been temporarily grounded and will be subject to further tests from the Transportation Ministry's aviation health division.
The drug test was conducted after FI had landed an AirAsia flight from Jakarta to Denpasar.(dyl/nfo)
